Brief: Arovella Therapeutics Announces Appointment of Tim Luscombe As Chief Financial Officer
Dec 1 (Reuters) - Arovella Therapeutics Ltd ALA.AX :
* COMPANY SECRETARY/CFO APPOINTMENT/RESIGNATION
* APPOINTMENT OF TIM LUSCOMBE AS CHIEF FINANCIAL OFFICER
* TIM LUSCOMBE REPLACES PHILLIP HAINS AS CFO
Source text for Eikon: ID:nASX7bxC62
Further company coverage: ALA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO